| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2144153 | Lung Cancer | 2006 | 7 Pages |
Abstract
Occurrence of chemotherapy induced grade 3 or 4 neutropenia correlated with OS in patients with SCLC receiving carboplatin and etoposide chemotherapy. Trials exploring controlled, safe intra-patient dose escalation with the intent of achieving grade 3 or 4 neutropenia in patients with SCLC are warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Udai Banerji, Sue Ashley, Jim Coward, Sarah Hughes, Ying Zee, Taqdir Benepal, Alison Norton, Tim Eisen, Mary O'Brien,